| Product |
CAS |
Molecular formula |
More |
| Piperazine,1-[5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl ]-4-(phen |
320417-87-6 |
C20H16F6N4O2S |
More |
| Piperazine,1-[5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl ]-4-[(4-c |
320417-95-6 |
C20H15ClF6N4O2S |
More |
| 4-Methyl-3-oxo-4-(1h-1,2,4-triazol-1-yl)pentanenitrile |
320420-58-4 |
|
More |
| Pyrazinecarboxamide,1-oxide (8ci,9ci) |
32046-08-5 |
C5H5N3O2 |
More |
| 2-Pentenenitrile,2-(2-oxopropyl)-,(2e)-(9ci) |
320572-83-6 |
C8H11NO |
More |
| 2-Propenenitrile,2-[[(2-cyanoethyl)methylamino]methyl ]-(9ci) |
320718-33-0 |
C8H11N3 |
More |
| Benzenamine,n-(cis-4-ethoxycyclohexyl)-(9ci) |
320725-75-5 |
C14H21NO |
More |
| 3-Cycloocten-1-ol ,2-(1-methylethyl)-,(1r,2r)-rel-(9ci) |
320743-11-1 |
C11H20O |
More |
| 2-Propenenitrile,3-(2s)-2-pyrrolidinyl-,(2e)-(9ci) |
320776-35-0 |
C7H10N2 |
More |
| 2-Imidazolidinone,1-acetyl-4-methoxy-(9ci) |
320778-06-1 |
C6H10N2O3 |
More |
| Cyclopentanecarboxylic acid,1-amino-2-methyl-,(1r,2s)-rel-(9ci) |
321157-21-5 |
C7H13NO2 |
More |
| Cyclopentanecarboxylic acid,1-amino-2-methyl-,(1r,2r)-rel-(9ci) |
321157-23-7 |
C7H13NO2 |
More |
| Cyclohexanecarboxylic acid,1,2-diamino-,(1r,2r)-rel-(9ci) |
321157-27-1 |
C7H14N2O2 |
More |
| 1,2,3-Cyclohexanetriol ,4-amino-,(1r,2r,3r,4s)-(9ci) |
321164-63-0 |
C6H13NO3 |
More |
| Carbamic acid,[(1r)-1-(aminomethyl)-3-methylbutyl ]-,1,1-dimethylethyl |
321328-70-5 |
C11H24N2O2 |
More |
| Cyclohexanone,5-methyl-2-(1-methylethylidene)-,oxime,(5s)-(9ci) |
321359-55-1 |
C10H17NO |
More |
| 1,2,4-Triazolidine-3,5-dione,4-hydroxy-1,2-dimethyl-(9ci) |
321372-26-3 |
C4H7N3O3 |
More |
| 1,8-Naphthyridine-2-acetonitrile,alpha-[(methoxyimino)methyl ]-5,7-bis |
321433-98-1 |
C14H8F6N4O |
More |
| 1H-pyrazol-5-amine,1-[5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl ] |
321522-20-7 |
C19H11F6N5 |
More |
| 1H-pyrazol-5-amine,1-[5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl ] |
321522-21-8 |
C20H13F6N5O |
More |
|
